The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Herbert B. Newton

Herbert B. Newton

MD Dardinger Neuro-Oncology Center

Department of Neurology

Ohio State University Medical Center

USA

[email]@osu.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Herbert B. Newton, MD Dardinger Neuro-Oncology Center, Department of Neurology, Ohio State University Medical Center, USA. 2006 - 2008
  • Dardinger Neuro-Oncology Center and Division of Neuro-Oncology, Department of Neurology, Ohio State University Medical Center, and James Cancer Hospital & Solove Research Institute, USA. 2000 - 2008
  • Department of Neurology, The Ohio State University, Columbus 43210, USA. 1999 - 2008
  • Dardinger Neuro-Oncology Center, Division of Neuro-Oncology, 465 Means Hall, 1654 Upham Drive, USA. 2004 - 2007

References

  1. Glioblastoma multiforme. Newton, H.B. Curr. Treat. Options. Neurol (2008) [Pubmed]
  2. Aggressive papillary glioneuronal tumor: case report and literature review. Newton, H.B., Dalton, J., Ray-Chaudhury, A., Gahbauer, R., McGregor, J. Clin. Neuropathol. (2008) [Pubmed]
  3. Do pilocytic astrocytomas have a benign course in adult patients?. Newton, H.B. Nature Clinical Practice. Neurology (2008) [Pubmed]
  4. Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors. Newton, H.B., Dalton, J., Goldlust, S., Pearl, D. J. Neurooncol. (2007) [Pubmed]
  5. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors. Newton, H.B. Curr. Opin. Investig. Drugs (2007) [Pubmed]
  6. Advances in strategies to improve drug delivery to brain tumors. Newton, H.B. Expert. Rev. Neurother (2006) [Pubmed]
  7. Incidence of infusion plan alterations after angiography in patients undergoing intra-arterial chemotherapy for brain tumors. Newton, H.B., Figg, G.M., Slone, H.W., Bourekas, E. J. Neurooncol. (2006) [Pubmed]
  8. Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. Newton, H.B., Goldlust, S.A., Pearl, D. J. Neurooncol. (2006) [Pubmed]
  9. Brain tumor imaging and cancer management: the neuro-oncologists perspective. Newton, H.B., Ray-Chaudhury, A., Cavaliere, R. Top. Magn. Reson. Imaging (2006) [Pubmed]
  10. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway. Newton, H.B. Expert. Rev. Anticancer. Ther (2005) [Pubmed]
  11. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle. Newton, H.B. Expert. Rev. Anticancer. Ther (2005) [Pubmed]
  12. Intra-arterial chemotherapy of primary brain tumors. Newton, H.B. Curr. Treat. Options. Oncol (2005) [Pubmed]
  13. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis. Newton, H.B. Expert. Rev. Anticancer. Ther (2004) [Pubmed]
  14. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 3: brain tumor invasiveness. Newton, H.B. Expert. Rev. Anticancer. Ther (2004) [Pubmed]
  15. Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up. Newton, H.B., Scott, S.R., Volpi, C. Br. J. Neurosurg (2004) [Pubmed]
  16. Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors. Newton, H.B., Slivka, M.A., Volpi, C., Bourekas, E.C., Christoforidis, G.A., Baujan, M.A., Slone, W., Chakeres, D.W. J. Neurooncol. (2003) [Pubmed]
  17. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: Growth factor and Ras signaling pathways. Newton, H.B. Expert. Rev. Anticancer. Ther (2003) [Pubmed]
  18. Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas. Newton, H.B., Slivka, M.A., Stevens, C.L., Bourekas, E.C., Christoforidis, G.A., Baujan, M.A., Chakeres, D.W. J. Neurooncol. (2002) [Pubmed]
  19. Chemotherapy for the treatment of metastatic brain tumors. Newton, H.B. Expert. Rev. Anticancer. Ther (2002) [Pubmed]
  20. Neurologic complications of scuba diving. Newton, H.B. Am. Fam. Physician (2001) [Pubmed]
  21. Review of the molecular genetics and chemotherapeutic treatment of adult and paediatric medulloblastoma. Newton, H.B. Expert. Opin. Investig. Drugs (2001) [Pubmed]
  22. Brain metastases from fallopian tube carcinoma responsive to intra-arterial carboplatin and intravenous etoposide: a case report. Newton, H.B., Stevens, C., Santi, M. J. Neurooncol. (2001) [Pubmed]
  23. Novel chemotherapeutic agents for the treatment of brain cancer. Newton, H.B. Expert. Opin. Investig. Drugs (2000) [Pubmed]
  24. Hydroxyurea chemotherapy for unresectable or residual meningioma. Newton, H.B., Slivka, M.A., Stevens, C. J. Neurooncol. (2000) [Pubmed]
  25. Clinical presentation, diagnosis, and pharmacotherapy of patients with primary brain tumors. Newton, H.B., Turowski, R.C., Stroup, T.J., McCoy, L.K. Ann. Pharmacother (1999) [Pubmed]
 
WikiGenes - Universities